Abstract

The use of percutaneous ablative techniques in the treatment of a variety of cancers and benign tumors is well documented with research supporting effective outcomes in appropriately selected patients. The following provides an overview of ablations performed for Medicare Beneficiaries by organ system.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call